🇺🇸 FDA
Patent

US 8613932

GP100-specific T cell receptors and related materials and methods of use

granted A61KA61K38/00A61P

Quick answer

US patent 8613932 (GP100-specific T cell receptors and related materials and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/00, A61P, A61P35/04